Literature DB >> 7570739

Amino acid uptake in ischemically compromised brain tissue.

A Jacobs1.   

Abstract

BACKGROUND AND
PURPOSE: Multitracer positron emission tomography (PET) was used to investigate local amino acid accumulation in brain tissue surrounding focal ischemia.
METHODS: PET using 15O-labeled oxygen and water for measuring cerebral metabolic rate of oxygen (CMRO2) and cerebral blood flow (CBF), C15O for determination of blood volume (CBV) and calculation of oxygen extraction fraction, and L-[11C]methylmethionine (11C-MET) for the assessment of amino acid accumulation was applied in 14 patients (mean age, 52 +/- 9.1 years) with acute ischemic hemispheric stroke. Two multitracer PET studies were completed, the first 8 to 24 hours after onset of neurological symptoms and the follow-up study 14 +/- 1 days after the ischemic attack. Functional changes were compared with morphological damage on cranial CT or MRI. Three-dimensional matching and volume of interest evaluation procedures were used to study 11C-MET accumulation in relation to various physiological variables in infarcted and noninfarcted tissue.
RESULTS: Compared with contralateral mirror regions, initially increased regional 11C-MET uptake (21.2 +/- 10.9%, P < .001) was found in patchy areas in the immediate vicinity of infarction as well as in distant areas within the same hemisphere. In those areas, regional CBF (-11.4 +/- 21.2%, P < .01) and oxygen extraction fraction (2.8 +/- 29.1%, P = NS) were highly variable, and regional CMRO2 was preserved or slightly reduced (-12.4 +/- 16.0%, P < .001). CBF data comprised severely ischemic as well as high values (14.6 to 64.2 mL/100 g per minute). Cranial CT and coregistered MRI in five patients demonstrated preserved morphology. In all peri-infarct areas (n = 62), the 11C-MET uptake showed a positive correlation with delta CMRO2 as the relative improvement of ipsilateral CMRO2 between the two PET studies (r = .378, P < .01). Particularly in areas with increased oxygen extraction fraction (n = 42), the 11C-MET uptake showed a mild correlation with CMRO2 at follow-up measurement (r = .31, P < .05). In all peri-infarct areas, 11C-MET uptake showed a negative correlation with oxygen extraction fraction (r = -.672, P < .001) and a positive correlation with CBF (r = .4, P = .001). In all infarcted and peri-infarct areas, normalized initial 11C-MET uptake was positively correlated with CMRO2 at follow-up (r = .603, P < .001).
CONCLUSIONS: Focal increases of 11C-MET uptake seen in this study were generally mild. They might be seen in the core of ischemia, indicating breakdown of the blood-brain barrier with poor tissue prognosis, but they also frequently occurred during or after ischemic compromise in surviving brain tissue surrounding focal cerebral infarction, perhaps representing alterations of amino acid transport or protein synthesis in brain tissue with a favorable prognosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7570739     DOI: 10.1161/01.str.26.10.1859

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Amino acid PET and clinical management of glioma patients.

Authors:  Karl Herholz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-28       Impact factor: 9.236

2.  Developmental Venous Anomalies Mimicking Neoplasm on 11C-Methionine PET and DSC Perfusion MRI.

Authors:  Julie H Harreld; Mikhail Doubrovin; Elizabeth R Butch; Angela Edwards; Barry Shulkin
Journal:  Clin Nucl Med       Date:  2017-05       Impact factor: 7.794

Review 3.  11C-methionine PET/CT findings in benign brain disease.

Authors:  Reiko Nakajima; Ken Kimura; Koichiro Abe; Shuji Sakai
Journal:  Jpn J Radiol       Date:  2017-04-18       Impact factor: 2.374

4.  Cortical dysplasia localized by [11C]methionine positron emission tomography: case report.

Authors:  Padma Vasantha Madakasira; Robert Simkins; Tanjore Narayanan; Kelly Dunigan; Raymond J Poelstra; Joseph Mantil
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

5.  [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence.

Authors:  S Ceyssens; K Van Laere; T de Groot; J Goffin; G Bormans; L Mortelmans
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

6.  Usefulness of (13)N-NH (3) PET in the evaluation of brain lesions that are hypometabolic on (18)F-FDG PET.

Authors:  Zhang Xiangsong; Chen Weian; Yue Dianchao; Wang Xiaoyan; Chen Zhifeng; Shi Xiongchong
Journal:  J Neurooncol       Date:  2011-04-19       Impact factor: 4.130

7.  Evaluation of brain tumors using dynamic 11C-methionine-PET.

Authors:  Tatsuki Aki; Noriyuki Nakayama; Shingo Yonezawa; Syunsuke Takenaka; Kazuhiro Miwa; Yoshitaka Asano; Jun Shinoda; Hirohito Yano; Toru Iwama
Journal:  J Neurooncol       Date:  2012-04-22       Impact factor: 4.130

8.  [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

Authors:  Markus Hutterer; Martha Nowosielski; Daniel Putzer; Nathalie L Jansen; Marcel Seiz; Michael Schocke; Mark McCoy; Georg Göbel; Christian la Fougère; Irene J Virgolini; Eugen Trinka; Andreas H Jacobs; Günther Stockhammer
Journal:  Neuro Oncol       Date:  2013-01-17       Impact factor: 12.300

9.  Diagnostics of cerebral gliomas with radiolabeled amino acids.

Authors:  Karl-Josef Langen; Klaus Tatsch; Anca-Ligia Grosu; Andreas H Jacobs; Matthias Weckesser; Osama Sabri
Journal:  Dtsch Arztebl Int       Date:  2008-01-25       Impact factor: 5.594

10.  Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma.

Authors:  Lutz W Kracht; Michael Friese; Karl Herholz; Roland Schroeder; Bernd Bauer; Andreas Jacobs; Wolf-Dieter Heiss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-12       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.